Cargando…
ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1
Molecular targeted therapy using poly (ADP-ribose) polymerase inhibitors has improved survival in patients with castration-resistant prostate cancer (CRPC). However, this approach is only effective in patients with specific genetic mutations, and additional drug discovery targeting epigenetic modula...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390525/ https://www.ncbi.nlm.nih.gov/pubmed/37524814 http://dx.doi.org/10.1038/s41598-023-39626-0 |